Journal article

Lack of durable remission with conventional-dose total skin electron therapy for the management of sezary syndrome and multiply relapsed mycosis fungoides

BA Campbell, G Ryan, C McCormack, E Tangas, M Bressel, R Twigger, O Buelens, C van der Weyden, HM Prince

Cancers | MDPI | Published : 2019

Abstract

Mycosis fungoides (MF) and Sezary syndrome (SS) are multi-relapsing, morbid, cutaneous T-cell lymphomas. Optimal treatment sequencing remains undefined. Total skin electron therapy (TSE) is a highly technical, skin-directed treatment, uniquely producing symptom-free and treatment-free intervals. Recent publications favour low-dose TSE for reduced toxicity, but early data support conventional-dose TSE (cdTSE) for longer disease control. Patient selection requires weighing-up tolerability against response durability. We investigated duration of benefit from cdTSE in patients with poorer prognosis diseases: SS and heavily pre-treated MF. Endpoints were overall survival, and “time to next treatm..

View full abstract